ZJYL: Jin Medical International Forvard P/E multiplikatori

zhjmedical.com (ZJYL) grafik logotipi

Reabilitatsiya uskunalarining global nishasining kengayishi va Jin Medical International (ZJYL) kompaniyasining Yaponiya va AQSh bozorlariga kirib borishi ijobiy dinamikani qo'llab-quvvatlamoqda. Kompaniyaning forward P/E NTM ko'rsatkichi emitentning to'lov qobiliyatini aks ettiradi va ushbu qiymat 0.00 darajasida saqlanmoqda. O'sish "aqlli" ishlanmalar va aholining qarishi bilan bog'liq, moderat narx belgilash imkoniyati esa noyob ultrayengil uglerod tolali nogironlar aravachalarining ishlab chiqarilishiga asoslangan.

Jin Medical International - ZJYL Narxning kutilayotgan foydaga nisbati (davr: 21.02.2024 - 18.11.2026)

Jin Medical (ZJYL) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Fundamental baholash:ZJYL Jin Medical International
zhjmedical.com brendining mahsuloti

Jin Medical International (ZJYL) reabilitatsiya uskunalariga bo‘lgan barqaror talab biznesning baholanishi uchun asos bo‘lib xizmat qiluvchi bashorat qilinadigan pul oqimini yaratadi. Kompaniyaning forward P/E grafigini tahlil qilish joriy bozor narxini kutilayotgan sof foyda bilan solishtirish imkonini beradi, bu esa aktivning qadrsizlanganligini yoki ushbu forward ko‘paytirgichning g‘ayritabiiy past qiymatlari holatida kapital stagnatsiyasi xatarlarini ochib beradi.

Jin Medical International raqobatchilari

Forvard P/E multiplikatori BSX|EW: Narxning kutilayotgan foydaga nisbati|ResMed Corp - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Insulet (PODD)|zimmerbiomet.com - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati CooperCompanies|ALGN: Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Globus Medical Corp (GMED)|TMDX (TransMedics Group Inc) - Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati ATEC (Alphatec)|Prognoz qilingan narxning foydaga nisbati AORT (Artivion)|ENOV (Enovis Corp) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Integra LifeSciences Inc. IART|ESTA - Prognoz qilingan narxning foydaga nisbati|Beta Bionics, Inc. - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati IRADIMED CORPORATION|EMBC: Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati TNDM|AXGN (Axogen Surgical) - Forvard P/E multiplikatori|SI-BONE Corp (SIBN) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Forvard P/E multiplikatori OFIX|Forvard P/E multiplikatori bioventus.com (BVS)|Forvard P/E multiplikatori KIDS (OrthoPediatrics Corp)|Forvard P/E multiplikatori Treace Medical Concepts Inc TMCI|SRTA - Kelajakdagi narxning foydaga nisbati|CARL: Kelajakdagi narxning foydaga nisbati|RXST (RxSight, Inc.) - Prognoz qilingan narxning foydaga nisbati|ClearPoint Neuro Inc. - Kelajakdagi narx-foyda multiplikatori|STXS (Stereotaxis Corporation) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Neuronetics Inc. STIM|Kelajakdagi narxning foydaga nisbati Sight Sciences Inc. (SGHT)|Orchestra BioMed, Inc. (OBIO) - Forvard narx-foyda multiplikatori|Anika Therapeutics Inc. - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori InspireMD, Inc. NSPR|Vivani Medical Inc - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Xtant Medical XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati MODD (Modular Med)|MYO (Myomo Inc.) - Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Envoy Medical, Inc. (COCH)|Forvard P/E multiplikatori VVOS|NVNO - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati sintx.com SINT|TNON: Narxning kelajakdagi foydaga nisbati|LFWD: Prognoz qilingan narxning foydaga nisbati|autonomix.com - Kapitalizatsiyaning kelajakdagi foydaga nisbati|INVO Bioscience, Inc. (IVF) - Kelajakdagi narxning foydaga nisbati|BBLG (Bone Biologics Corp.) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati AXNX|Biolase Inc. (BIOL) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati Dynatronics Corp. (DYNT)|Forvard P/E multiplikatori Paragon 28 (FNA)|Kelajakdagi narxning foydaga nisbati INVO Bioscience INVO